July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Vivek Subbiah Highlights STELLAR-303 Trial Results for Zanzalintinib Combo in mCRC
Jun 25, 2025, 08:29

Vivek Subbiah Highlights STELLAR-303 Trial Results for Zanzalintinib Combo in mCRC

Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on X:

“Press release Exelixis Announces Zanzalintinib in Combination with an Immune Checkpoint Inhibitor Improved Overall Survival in STELLAR-303 Phase 3 Pivotal Trial in Patients with Metastatic Colorectal Cancer | Exelixis, Inc.”

Read further.